Literature DB >> 11742913

Methacholine challenge: test-shortening procedures.

D W Cockcroft1, D D Marciniuk, T S Hurst, D J Cotton, K F Laframboise, B D McNab, R P Skomro.   

Abstract

STUDY
OBJECTIVES: Validation of test-shortening procedures for the 2-min tidal breathing methacholine challenge method.
DESIGN: Retrospective chart review.
SETTING: Tertiary-care university clinical pulmonary function laboratory. PATIENTS: One thousand subjects aged 10 to 85 years (mean +/- SD, 44.5 +/- 16.0 years), 44.5% male, referred for methacholine challenge. INTERVENTION: Two-minute tidal breathing methacholine challenge was performed, with both physician and technician access to published test-shortening procedures. MEASUREMENTS AND
RESULTS: There were 315 positive test results (provocative concentration of methacholine causing a 20% fall in FEV(1) [PC(20)] < or = 8 mg/mL) and 685 negative test results. The subjects with positive test results were less likely to be male (39.1 vs 47.5%; p < 0.02) and had lower FEV(1) (91.8 +/- 14.9% predicted vs 97.2 +/- 13.9% predicted; p < 0.001). The average starting PC(20) was between 0.5 mg/mL and 1.0 mg/mL; the most common PC(20) was 1 mg/mL (67%). There were 431 skipped concentrations in 380 subjects. The mean number of methacholine inhalations was 3.7 +/- 1.1 (3.9 +/- 0.1 for negative test results vs 3.3 +/- 1.2 for positive test results; p < 0.001). Eighteen subjects had a > or = 20% FEV(1) fall on the first inhalation, and 11 subjects had a > or = 20% FEV(1) fall after a skipped concentration. In only one case (0.1%) an FEV(1) fall > or = 40% on the first concentration was reported, compared with no cases after a skipped concentration and seven cases with a > or = 40% FEV(1) fall after a routine doubling dose step-up.
CONCLUSIONS: The 2-min tidal breathing methacholine test in clinical practice can be safely shortened to an average of less than four inhalations using starting concentrations based on FEV(1), asthma medication, and clinical features, and by occasionally omitting concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742913     DOI: 10.1378/chest.120.6.1857

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness.

Authors:  Antonio Z Politi; Graham M Donovan; Merryn H Tawhai; Michael J Sanderson; Anne-Marie Lauzon; Jason H T Bates; James Sneyd
Journal:  J Theor Biol       Date:  2010-08-04       Impact factor: 2.691

Review 2.  Bronchoprovocation methods: direct challenges.

Authors:  Donald W Cockcroft
Journal:  Clin Rev Allergy Immunol       Date:  2003-02       Impact factor: 10.817

3.  The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma.

Authors:  Graeme P Currie; Tom C Fardon; Daniel Kc Lee
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

4.  Dose omission to shorten methacholine challenge testing: clinical consequences of the use of a 10% fall in FEV1 threshold.

Authors:  Valérie Lévesque; Claude Poirier; Bruno-Pierre Dubé
Journal:  Allergy Asthma Clin Immunol       Date:  2018-12-19       Impact factor: 3.406

5.  Use of a vibrating mesh nebulizer for allergen challenge.

Authors:  Donald W Cockcroft; Beth E Davis; Christianne M Blais; Louis-Philippe Boulet; Marie-Éve Boulay; Hélène Villeneuve; Gail M Gauvreau; Paul M O'Byrne; Karen J Howie; Caitlin D Obminski
Journal:  Allergy Asthma Clin Immunol       Date:  2019-11-26       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.